Ethan Phd Shen Buys 3,100 Shares of YD Bio (NASDAQ:YDES) Stock

YD Bio Limited (NASDAQ:YDES) CEO Ethan Shen purchased 3,100 shares of YD Bio stock in a transaction that occurred on Wednesday, September 9th. The shares were bought at an average cost of $3.93 per share, for a total transaction of $12,183.00. Following the completion of the transaction, the chief executive officer directly owned 11,245,631 shares in the company, valued at $44,195,329.83. This represents a 0.03% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.

YD Bio Stock Up 2.6%

Shares of NASDAQ:YDES opened at $4.00 on Friday. YD Bio Limited has a 52-week low of $1.70 and a 52-week high of $25.00. The company has a 50 day moving average of $3.02 and a two-hundred day moving average of $4.52.

YD Bio (NASDAQ:YDES) last posted its quarterly earnings data on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million for the quarter.

Institutional Trading of YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC boosted its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.